Delayed cell death associated with mitotic catastrophe in γ-irradiated stem-like glioma cells

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Firat, Elke ^a   Gaedicke, Simone ^a   Tsurumi, Chizuko ^a   Esser, Norbert ^b   Weyerbrock, Astrid ^a   Niedermann, Gabriele ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b PROQINASE GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; DNA; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HISTONE H2AX; PROTEIN P21; PROTEIN P53; H2AFX PROTEIN, HUMAN; HISTONE;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DNA DAMAGE; GAMMA IRRADIATION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MITOSIS INHIBITION; PROTEIN EXPRESSION; RADIATION DOSE; RADIOSENSITIVITY; WESTERN BLOTTING; BRAIN TUMOR; CANCER STEM CELL; GAMMA RADIATION; GLIOMA; IONIZING RADIATION; METABOLISM; MITOSIS; PATHOLOGY; RADIATION EXPOSURE;

APOPTOSIS; BRAIN NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GAMMA RAYS; GLIOMA; HISTONES; HUMANS; MITOSIS; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; RADIATION, IONIZING;

EID: 79958110216     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-71     Document Type: Article

References (52)

1. O'Brien CA, Kreso A, Dick JE. Cancer stem cells in solid tumors: an overview. Semin Radiat Oncol 2009, 19(2):71-77. 10.1016/j.semradonc.2008.11.001, 19249644.
2. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer 2006, 6(6):425-436. 10.1038/nrc1889, 16723989.
3. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea--a paradigm shift. Cancer Res 2006, 66(4):1883-1890. 10.1158/0008-5472.CAN-05-3153, 16488983.
4. Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C, De Maria R. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006, 13(7):1238-1241. 10.1038/sj.cdd.4401872, 16456578.
5. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006, 5:67. 10.1186/1476-4598-5-67, 1697823, 17140455.
6. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444(7120):756-760. 10.1038/nature05236, 17051156.
7. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006, 98(24):1777-1785. 10.1093/jnci/djj495, 17179479.
8. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 2007, 104(2):618-623. 10.1073/pnas.0606599104, 1766434, 17202265.
9. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1(3):313-323. 10.1016/j.stem.2007.06.002, 18371365.
10. Hambardzumyan D, Becher OJ, Rosenblum MK, Pandolfi PP, Manova-Todorova K, Holland EC. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev 2008, 22(4):436-448. 10.1101/gad.1627008, 2238666, 18281460.
11. Chiou SH, Kao CL, Chen YW, Chien CS, Hung SC, Lo JF, Chen YJ, Ku HH, Hsu MT, Wong TT. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One 2008, 3(5):e2090. 10.1371/journal.pone.0002090, 2396792, 18509505.
12. Kao CL, Huang PI, Tsai PH, Tsai ML, Lo JF, Lee YY, Chen YJ, Chen YW, Chiou SH. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int J Radiat Oncol Biol Phys 2009, 74(1):219-228. 10.1016/j.ijrobp.2008.12.035, 19362240.
13. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458(7239):780-783. 10.1038/nature07733, 2778612, 19194462.
14. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009, 16(1):3-11. 10.1038/cdd.2008.150, 2744427, 18846107.
15. Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005, 5(3):231-237. 10.1038/nrc1560, 15738985.
16. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ 2008, 15(7):1153-1162. 10.1038/cdd.2008.47, 18404154.
17. Zhang P, Castedo M, Tao Y, Violot D, Metivier D, Deutsch E, Kroemer G, Bourhis J. Caspase independence of radio-induced cell death. Oncogene 2006, 25(59):7758-7770. 10.1038/sj.onc.1209744, 16862186.
18. McCord AM, Jamal M, Williams ES, Camphausen K, Tofilon PJ. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clin Cancer Res 2009, 15(16):5145-5153. 10.1158/1078-0432.CCR-09-0263, 19671863.
19. Ropolo M, Daga A, Griffero F, Foresta M, Casartelli G, Zunino A, Poggi A, Cappelli E, Zona G, Spaziante R, et al. Comparative analysis of DNA repair in stem and nonstem glioma cell cultures. Mol Cancer Res 2009, 7(3):383-392. 10.1158/1541-7786.MCR-08-0409, 19276180.
20. Frosina G. DNA repair and resistance of gliomas to chemotherapy and radiotherapy. Mol Cancer Res 2009, 7(7):989-999. 10.1158/1541-7786.MCR-09-0030, 19609002.
21. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009, 4(6):568-580. 10.1016/j.stem.2009.03.014, 19497285.
22. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401. 10.1038/nature03128, 15549107.
23. Beier CP, Beier D. CD133 negative cancer stem cells in glioblastoma. Front Biosci (Elite Ed) 2011, 3:701-710.
24. Campos B, Herold-Mende CC. Insight into the complex regulation of CD133 in glioma. Int J Cancer 2011, 128(3):501-510. 10.1002/ijc.25687, 20853315.
25. Wang J, Sakariassen PO, Tsinkalovsky O, Immervoll H, Boe SO, Svendsen A, Prestegarden L, Rosland G, Thorsen F, Stuhr L, et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 2008, 122(4):761-768. 10.1002/ijc.23130, 17955491.
26. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, Greve JM, Soriano RH, Gilmour LL, Rivers CS, et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 2010, 17(4):362-375. 10.1016/j.ccr.2009.12.049, 20385361.
27. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255(5052):1707-1710. 10.1126/science.1553558, 1553558.
28. Fael Al-Mayhani TM, Ball SL, Zhao JW, Fawcett J, Ichimura K, Collins PV, Watts C. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. J Neurosci Methods 2009, 176(2):192-199. 10.1016/j.jneumeth.2008.07.022, 19215724.
29. Jonathan EC, Bernhard EJ, McKenna WG. How does radiation kill cells?. Curr Opin Chem Biol 1999, 3(1):77-83. 10.1016/S1367-5931(99)80014-3, 10021401.
30. Lipani JD, Jackson PS, Soltys SG, Sato K, Adler JR. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme. Technol Cancer Res Treat 2008, 7(3):249-255.
31. Rodemann HP, Dittmann K, Toulany M. Radiation-induced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol 2007, 83(11-12):781-791. 10.1080/09553000701769970, 18058366.
32. Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz JL, Seddon AP, Cordon-Cardo C, Haimovitz-Friedman A. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 1994, 54(10):2582-2590.
33. Ader I, Muller C, Bonnet J, Favre G, Cohen-Jonathan E, Salles B, Toulas C. The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunit. Oncogene 2002, 21(42):6471-6479. 10.1038/sj.onc.1205838, 12226750.
34. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005, 16(2):139-149. 10.1016/j.cytogfr.2005.01.001, 15863030.
35. Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T, Ramos-Mejia V, Rouleau A, Yang J, Bosse M, et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 2007, 448(7157):1015-1021. 10.1038/nature06027, 17625568.
36. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352(10):987-996. 10.1056/NEJMoa043330, 15758009.
37. Norbury CJ, Zhivotovsky B. DNA damage-induced apoptosis. Oncogene 2004, 23(16):2797-2808. 10.1038/sj.onc.1207532, 15077143.
38. Garner E, Raj K. Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death. Cell Cycle 2008, 7(3):277-282. 10.4161/cc.7.3.5328, 18235223.
39. Ianzini F, Bertoldo A, Kosmacek EA, Phillips SL, Mackey MA. Lack of p53 function promotes radiation-induced mitotic catastrophe in mouse embryonic fibroblast cells. Cancer Cell Int 2006, 6:11. 10.1186/1475-2867-6-11, 1479380, 16640786.
40. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 2007, 170(5):1445-1453. 10.2353/ajpath.2007.070011, 1854940, 17456751.
41. Shu HK, Kim MM, Chen P, Furman F, Julin CM, Israel MA. The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression. Proc Natl Acad Sci USA 1998, 95(24):14453-14458. 10.1073/pnas.95.24.14453, 24394, 9826721.
42. Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 2003, 3(2):117-130. 10.1016/S1535-6108(03)00021-7, 12620407.
43. Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 2000, 60(2):417-424.
44. Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA, et al. The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res 2009, 69(7):2809-2816. 10.1158/0008-5472.CAN-08-4079, 2859885, 19339267.
45. Kriegs M, Kasten-Pisula U, Rieckmann T, Holst K, Saker J, Dahm-Daphi J, Dikomey E. The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining. DNA Repair (Amst) 2010, 9(8):889-897.
46. Harfouche G, Vaigot P, Rachidi W, Rigaud O, Moratille S, Marie M, Lemaitre G, Fortunel NO, Martin MT. Fibroblast growth factor type 2 signaling is critical for DNA repair in human keratinocyte stem cells. Stem Cells 2010, 28(9):1639-1648. 10.1002/stem.485, 2996082, 20681019.
47. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449(7165):1003-1007. 10.1038/nature06196, 17934449.
48. Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, Todaro M, Stassi G, Martini M, Maira G, Larocca LM, et al. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 2008, 14(24):8205-8212. 10.1158/1078-0432.CCR-08-0644, 19088037.
49. Sun Y, Kong W, Falk A, Hu J, Zhou L, Pollard S, Smith A. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PLoS One 2009, 4(5):e5498. 10.1371/journal.pone.0005498, 2676510, 19430532.
50. Trumpp A, Essers M, Wilson A. Awakening dormant haematopoietic stem cells. Nat Rev Immunol 2010, 10(3):201-209. 10.1038/nri2726, 20182459.
51. Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, Sone A, Najima Y, Takagi S, Aoki Y, Wake A, et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol 2010, 28(3):275-280.
52. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem 2000, 275(13):9390-9395. 10.1074/jbc.275.13.9390, 10734083.